Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (81-90 of 375) with videos related to

Pageof 38
Sort By:
Life (Basel, Switzerland)|April 28, 2023
Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young WomenElze Prokurotaite, Margherita Condorelli, Julie Dechene, et al.
International Journal of Women'S Health|August 27, 2019
Triple-negative breast cancer: current perspective on the evolving therapeutic landscapeJoe Mehanna, Fady Gh Haddad, Roland Eid, et al.
Breast Cancer Research and Treatment|January 25, 2022
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patientsMaria Alice Franzoi, Matteo Lambertini, Marcello Ceppi, et al.
Breast Care (Basel, Switzerland)|April 2, 2020
Highlights from ABC5: Bridging the GapRachel Wuerstlein, Carlos Barrios, Matteo Lambertini, et al.
Cancer Biology & Medicine|March 17, 2018
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidencesFedro Alessandro Peccatori, Matteo Lambertini, Giovanna Scarfone, et al.
Therapeutic Advances in Medical Oncology|March 6, 2019
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectivesRafael Caparica, Matteo Lambertini, Noam Pondé, et al.
Eclinicalmedicine|June 17, 2026
Oncofertility outcomes in early-onset patients with non-breast solid malignancies: a systematic reviewNatali Shirron, Andrea Boutros, Ithai Waldhorn, et al.
Cancer Treatment Reviews|May 28, 2017
State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literatureClaudia Massarotti, Paola Scaruffi, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2020
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancerNoam Pondé, Lieveke Ameye, Matteo Lambertini, et al.
Oncotargets and Therapy|July 27, 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinibHampig Raphael Kourie, Elie El Rassy, Florian Clatot, et al.
Pageof 38

Showing results (81-90 of 375) with videos related to

Sort By:
Pageof 38
Life (Basel, Switzerland)|April 28, 2023
Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young WomenElze Prokurotaite, Margherita Condorelli, Julie Dechene, et al.
International Journal of Women'S Health|August 27, 2019
Triple-negative breast cancer: current perspective on the evolving therapeutic landscapeJoe Mehanna, Fady Gh Haddad, Roland Eid, et al.
Breast Cancer Research and Treatment|January 25, 2022
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patientsMaria Alice Franzoi, Matteo Lambertini, Marcello Ceppi, et al.
Breast Care (Basel, Switzerland)|April 2, 2020
Highlights from ABC5: Bridging the GapRachel Wuerstlein, Carlos Barrios, Matteo Lambertini, et al.
Cancer Biology & Medicine|March 17, 2018
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidencesFedro Alessandro Peccatori, Matteo Lambertini, Giovanna Scarfone, et al.
Therapeutic Advances in Medical Oncology|March 6, 2019
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectivesRafael Caparica, Matteo Lambertini, Noam Pondé, et al.
Eclinicalmedicine|June 17, 2026
Oncofertility outcomes in early-onset patients with non-breast solid malignancies: a systematic reviewNatali Shirron, Andrea Boutros, Ithai Waldhorn, et al.
Cancer Treatment Reviews|May 28, 2017
State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literatureClaudia Massarotti, Paola Scaruffi, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2020
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancerNoam Pondé, Lieveke Ameye, Matteo Lambertini, et al.
Oncotargets and Therapy|July 27, 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinibHampig Raphael Kourie, Elie El Rassy, Florian Clatot, et al.
Pageof 38